Molecular Diagnostics of Gliomas Using Next Generation Sequencing of a Glioma‐Tailored Gene Panel

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Brain Pathology

• Publication date

  2017-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/bpa.12367PMID 26919320PMCID PMC8029406
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets

  2016cited by this paper
• Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.

  2016cited by this paper
• Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors.

  2016cited by this paper
• Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.

  2015cited by this paper
• Functionally-defined Therapeutic Targets in Diffuse Intrinsic Pontine Glioma

  2015cited by this paper
• Molecular Pathways in Gliomagenesis and Their Relevance to Neuropathologic Diagnosis

  2015influential reference
• A wide spectrum of EGFR mutations in glioblastoma is detected by a single clinical oncology targeted next-generation sequencing panel.

  2015cited by this paper
• Molecular Classification of Ependymal Tumors across All CNS Compartments, Histopathological Grades, and Age Groups.

  2015cited by this paper
• Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups

  2015cited by this paper
• The efficacy of uracil DNA glycosylase pretreatment in amplicon-based massively parallel sequencing with DNA extracted from archived formalin-fixed paraffin-embedded esophageal cancer tissues.

  2015cited by this paper
• Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcoma.

  2015cited by this paper
• Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.

  2015influential reference
• Mutational landscape and clonal architecture in grade II and III gliomas

  2015cited by this paper
• A phase II, multicenter trial of rindopepimut (CDX-110) in newly diagnosed glioblastoma: the ACT III study.

  2015influential reference
• Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities

  2015cited by this paper
• Glioma

  2015cited by this paper
• Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma.

  2015cited by this paper
• Sequence artifacts in DNA from formalin-fixed tissues: causes and strategies for minimization.

  2015cited by this paper
• ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma

  2014cited by this paper
• Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours

  2014cited by this paper
• EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma.

  2014cited by this paper
• C11orf95-RELA fusions drive oncogenic NF-κB signaling in ependymoma

  2014cited by this paper
• A vaccine targeting mutant IDH1 induces antitumour immunity

  2014influential reference
• Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma

  2014cited by this paper
• Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study

  2014cited by this paper
• Anchored multiplex PCR for targeted next-generation sequencing

  2014cited by this paper
• BRAF‐Mutated Pleomorphic Xanthoastrocytoma is Associated with Temporal Location, Reticulin Fiber Deposition and CD34 Expression

  2014cited by this paper
• Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas

  2014cited by this paper
• Clinical multiplexed exome sequencing distinguishes adult oligodendroglial neoplasms from astrocytic and mixed lineage gliomas

  2014cited by this paper
• Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations

  2014cited by this paper
• Pharmacologic inhibition of histone demethylation as a therapy for pediatric brainstem glioma

  2014cited by this paper
• A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas

  2014cited by this paper
• Integrated DNA methylation and copy-number profiling identify three clinically and biologically relevant groups of anaplastic glioma

  2014influential reference
• International Society of Neuropathology‐Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading

  2014influential reference
• Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy

  2014influential reference
• The somatic genomic landscape of glioblastoma.

  2013cited by this paper
• Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma

  2013cited by this paper
• Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays

  2013cited by this paper
• TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

  2013cited by this paper
• Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.

  2013cited by this paper
• Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas

  2013cited by this paper
• Prospective, high-throughput molecular profiling of human gliomas

  2012cited by this paper
• Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

  2012cited by this paper
• Somatic Histone H3 Alterations in Paediatric Diffuse Intrinsic Pontine Gliomas and Non-Brainstem Glioblastomas

  2012cited by this paper
• Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma

  2012cited by this paper
• Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations

  2012cited by this paper
• Whole exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma

  2012cited by this paper
• Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil-DNA glycosylase

  2012influential reference
• Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma

  2011cited by this paper
• Integrative Genomics Viewer

  2011cited by this paper
• Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody

  2011cited by this paper
• Immunologic escape after prolonged progression-free survival with epidermal growth factor receptor variant III peptide vaccination in patients with newly diagnosed glioblastoma.

  2010influential reference
• A method and server for predicting damaging missense mutations

  2010cited by this paper
• Molecular diagnostics of gliomas: state of the art

  2010cited by this paper
• ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

  2010cited by this paper
• Rapid and sensitive assessment of the IDH1 and IDH2 mutation status in cerebral gliomas based on DNA pyrosequencing

  2010cited by this paper
• Sample type bias in the analysis of cancer genomes.

  2009cited by this paper
• Monoclonal antibody specific for IDH1 R132H mutation

  2009cited by this paper
• Adaptive evolution of young gene duplicates in mammals.

  2009cited by this paper
• Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm

  2009cited by this paper
• Identification of deleterious mutations within three human genomes.

  2009cited by this paper
• The 2007 WHO Classification of Tumours of the Central Nervous System

  2007cited by this paper
• Frequent loss of chromosome 9, homozygous CDKN2A/p14ARF/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas

  2007cited by this paper
• New Methods for Detecting Lineage-Specific Selection

  2006cited by this paper
• Oligodendroglial Tumors: Refinement of Candidate Regions on Chromosome Arm 1p and Correlation of 1p/19q Status with Survival

  2004cited by this paper
• Pathogenesis of Tuberous Sclerosis Subependymal Giant Cell Astrocytomas: Biallelic Inactivation of TSC1 or TSC2 Leads to mTOR Activation

  2004cited by this paper
• Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

  2001cited by this paper
• CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas.

  1994cited by this paper
• The classification of tumours of the central nervous system.

  1982influential reference

• Impact of an evolving classification system on diffuse glioma repositories: experience from the Sydney brain tumour bank

  2026cites this paper
• From Data to Decision: Integrating Bioinformatics into Glioma Patient Stratification and Immunotherapy Selection

  2026cites this paper
• Navigating molecular neuropathology of CNS neoplasms for the practicing surgical pathologist.

  2025cites this paper
• Strong nuclear expression of HOXB13 is a reliable surrogate marker for DNA methylome profiling to distinguish myxopapillary ependymoma from spinal ependymoma

  2025cites this paper
• Distinct molecular profile and outcome of oligodendroglioma, IDH-mutant, 1p/19q-codeleted, and TERTp-wildtype: A grade 1 oligodendroglioma of young patients?

  2025cites this paper
• Evaluation of the Effect of X-Ray Therapy on Glioma Rat Model Using Chemical Exchange Saturation Transfer and Diffusion-Weighted Imaging

  2025cites this paper
• Response to the Letter to the Editor Shankar et al.: Metformin as an Adjunct Treatment to Temozolomide for High-Grade Gliomas: A Systematic Review and Meta-Analysis.

  2025cites this paper
• Prognostic implication of CDKN2A/B homozygous deletion on histological grades in isocitrate dehydrogenase-mutant astrocytomas: A systematic review and meta-analysis

  2025cites this paper
• Ultra-Fast Intraoperative IDH-Mutation Analysis Enables Rapid Stratification and Therapy Planning in Diffuse Gliomas

  2025cites this paper
• 5T chemical exchange saturation transfer imaging improves glioma grading and genotyping prediction: a supplement to 3T diffusion and perfusion MRI

  2025cites this paper
• Liquid Biopsy of Plasma and Cerebrospinal Fluid for the Detection of Extracellular Tumor DNA as a Tool for Glioma Diagnosis and Genotyping: A Cross-Sectional Observational Pilot Study

  2025cites this paper
• TERT Promoter Mutation Analysis in Glioma Samples by Allele-Specific Biochip Hybridization

  2025cites this paper
• Structural alterations of the EGFR gene in glioblastoma samples as a prognostic factor and molecular target for therapy

  2024cites this paper
• Microglia induce an interferon‐stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide

  2024cites this paper
• Mass Spectrometry Advances in Analysis of Glioblastoma

  2024cites this paper
• IDH Mutations in Glioma: Molecular, Cellular, Diagnostic, and Clinical Implications

  2024cites this paper
• HPV is an essential driver in recurrence of cervical cancer.

  2024cites this paper
• Diagnostic challenges in complicated case of glioblastoma

  2024cites this paper
• A clinically feasible algorithm for the parallel detection of glioma‐associated copy number variation markers based on shallow whole genome sequencing

  2024cites this paper
• All-in-one bimodal DNA and RNA next-generation sequencing panel for integrative diagnosis of glioma.

  2024cites this paper
• Complex Diagnostic Challenges in Glioblastoma: The Role of 18F-FDOPA PET Imaging

  2024cites this paper
• A clinically compatible in vitro drug-screening platform identifies therapeutic vulnerabilities in primary cultures of brain metastases

  2024cites this paper
• Glioblastoma: A molecular insight into current discoveries and treatment directions

  2024cites this paper
• Potential Diagnostic and Clinical Significance of Selected Genetic Alterations in Glioblastoma

  2024cites this paper
• Expression of KCNN4 in adult-type diffuse gliomas and its correlations with clinicopathological features and patient prognosis

  2024cites this paper
• Prognostic factors to predict postoperative survival in patients with recurrent glioblastoma

  2024cites this paper
• PDP type brain tumor in association with multiple endocrine neoplasia type 1

  2024cites this paper
• The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma

  2024cites this paper
• Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma

  2024cites this paper
• Evaluation of the Expression of miRNAs, LncRNAs, and their Target Gene, Caspase 3 in Glioblastoma Multiform: A Case–Control Study

  2023cites this paper
• Characterization of the mutational landscape of high-grade gliomas in a Latin American cohort

  2023cites this paper
• Comprehensive clinical assays for molecular diagnostics of gliomas: the current state and future prospects

  2023cites this paper
• Model incorporating multiple diffusion MRI features: development and validation of a radiomics-based model to predict adult-type diffuse gliomas grade

  2023cites this paper
• Activated KRAS reprograms neural progenitor cells to glioma stem cell-like phenotype

  2023cites this paper
• Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline

  2023cites this paper
• The Glioma-IRE project − Molecular profiling in patients with glioma: steps toward an individualized diagnostic and therapeutic approach

  2023cites this paper
• Ductal adenoma with AKT1 and EGFR mutations: Report of a case and review of literature

  2023cites this paper
• Proteome-based insights for IDH-mutant glioma classification

  2023cites this paper
• Applying MAP-MRI to Identify the WHO Grade and Main Genetic Features of Adult-type Diffuse Gliomas: A Comparison of Three Diffusion-weighted MRI Models.

  2022cites this paper
• Molecular profile and clinical features of patients with gliomas using a broad targeted next generation-sequencing panel.

  2022cites this paper
• Construction of a prognostic classifier and prediction of the immune landscape and immunosuppressive molecules in gliomas based on combination of inflammatory response-related genes and angiogenesis-associated genes

  2022cites this paper
• Impact of new molecular criteria on diagnosis and survival of adult glioma patients

  2022cites this paper
• LINC01426 aggravates the malignant progression of glioma through miR-661/Mdm2 axis.

  2022cites this paper
• Determination of IDH1, IDH2, MGMT, TERT and ATRX Gene Mutations in Glial Tumors

  2022cites this paper
• The Value of FET PET/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers

  2022cites this paper
• Distribution and favorable prognostic implication of genomic EGFR alterations in IDH ‐wildtype glioblastoma

  2022cites this paper
• Utility of Targeted Next-Generation Sequencing Assay to Detect 1p/19q Co-Deletion in Formalin-fixed Paraffin-embedded Glioma Specimens.

  2022cites this paper
• Evaluation of Temozolomide Treatment for Glioblastoma Using Amide Proton Transfer Imaging and Diffusion MRI

  2022cites this paper
• Droplet digital PCR-based analyses for robust, rapid, and sensitive molecular diagnostics of gliomas

  2022cites this paper
• Detection of TERT Promoter Mutations as a Prognostic Biomarker in Gliomas: Methodology, Prospects, and Advances

  2022influential citation
• Natural Compounds as Promising Adjuvant Agents in The Treatment of Gliomas

  2022cites this paper
• A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications

  2022cites this paper
• Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma.

  2022cites this paper
• A new amplicon‐based gene panel for next generation sequencing characterization of meningiomas

  2022cites this paper
• Targeted next generation sequencing provides insight for the genetic alterations in liquid biopsy of Egyptian brain tumor patients

  2022cites this paper
• Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas.

  2022cites this paper
• State-of-the-Art Explainability Methods with Focus on Visual Analytics Showcased by Glioma Classification

  2022cites this paper
• The evolution of pleomorphic xanthoastrocytoma: from genesis to molecular alterations and mimics

  2022cites this paper
• IDH-mutant astrocytoma with an evolutional progression to CDKN2A/B homozygous deletion and NTRK fusion during recurrence: A case report.

  2022cites this paper
• Digital PCR-Based Method for Detecting CDKN2A Loss in Brain Tumours

  2022cites this paper
• Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation

  2021cites this paper
• TERT Promoter Alterations in Glioblastoma: A Systematic Review

  2021cites this paper
• IDH1 Non-Canonical Mutations and Survival in Patients with Glioma

  2021cites this paper
• The Past, Present and Future of Flow Cytometry in Central Nervous System Malignancies

  2021cites this paper
• DNA hydroxymethylation in high-grade gliomas

  2021cites this paper
• IDH1/2 Mutations in Patients With Diffuse Gliomas: A Single Centre Retrospective Massively Parallel Sequencing Analysis

  2021cites this paper
• Machine learning modeling of genome-wide copy number alteration signatures reliably predicts IDH mutational status in adult diffuse glioma

  2021cites this paper
• Detection of EGFR Mutation Distribution and Transcriptional Variants in IDH-wildtype High-grade Gliomas using a Next-generation Sequencing Oncopanel

  2021cites this paper
• Longitudinal stability of molecular alterations and drug response profiles in tumor spheroid cell lines enables reproducible analyses.

  2021cites this paper
• Biological functions of miRNA-188-5p/XRCC5 in glioma

  2021cites this paper
• Comprehensive Molecular Characterization of Chinese Patients with Glioma by Extensive Next-Generation Sequencing Panel Analysis

  2021cites this paper
• TERT promoter hotspot mutations and gene amplification in metaplastic breast cancer

  2021cites this paper
• Serum lncRNA-ANRIL and SOX9 expression levels in glioma patients and their relationship with poor prognosis

  2021cites this paper
• Next generation sequencing impacts the classification and management of primary brain tumours.

  2021cites this paper
• Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients

  2021cites this paper
• The Prognostic Value of Methylation Signatures and NF2 Mutations in Atypical Meningiomas

  2021cites this paper
• The multi-target small-molecule inhibitor SB747651A shows in vitro and in vivo anticancer efficacy in glioblastomas

  2021cites this paper
• Adult precision medicine: learning from the past to enhance the future

  2020cites this paper
• Dissecting Molecular Features of Gliomas: Genetic Loci and Validated Biomarkers

  2020cites this paper
• Nanomedicine and Immunotherapy: A Step Further towards Precision Medicine for Glioblastoma

  2020cites this paper
• LncRNA HANR aggravates the malignant progression of glioma via targeting miRNA-335.

  2020cites this paper
• Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma

  2020cites this paper
• Rapid development of an atypical meningioma during Nivolumab therapy for metastatic renal cell carcinoma.

  2020cites this paper
• Targeted next‐generation sequencing of adult gliomas for retrospective prognostic evaluation and up‐front diagnostics

  2020cites this paper
• ABCC8 mRNA expression is an independent prognostic factor for glioma and can predict chemosensitivity

  2020cites this paper
• Multiple formin proteins participate in glioblastoma migration

  2020cites this paper
• A comprehensive DNA panel next generation sequencing approach supporting diagnostics and therapy prediction in neurooncology

  2020cites this paper
• A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma

  2020cites this paper
• A tailored next‐generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas

  2020cites this paper
• Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX Mutations

  2020influential citation
• Clinical practice guidelines for the management of adult diffuse gliomas.

  2020cites this paper
• The molecular evolution of glioblastoma treated by gross total resection alone.

  2020cites this paper
• EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood

  2020cites this paper
• Stereotaktische Hirnbiopsien

  2020cites this paper
• Investigation of dacomitinib on reducing cell necrosis and enhancing cell apoptosis in C6 glioma rat model by MRI

  2019cites this paper
• Quantitative Proteomics Reveals Global Reduction of Endocytic Machinery Components in Gliomas

  2019cites this paper
• Somatic gene mutation signatures predict cancer type and prognosis in multiple cancers with Pan-Cancer 1000 gene panel.

  2019cites this paper
• Seven genes for the prognostic prediction in patients with glioma

  2019cites this paper
• Relevance of Steroid Biosynthesis, Metabolism and Transport in Pathophysiology and Drug Discovery

  2019cites this paper
• Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches

  2019cites this paper